Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

DBV Submits BLA For VIASKIN Peanut Patch In Children With Peanut Allergy

(RTTNews) - DBV Technologies (DBVT) announced the submission of a Biologics License Application to the U.S. FDA for the VIASKIN Peanut Patch in children aged 4 to 7 years with peanut allergy.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Wednesday 30 September →